Health ❯Healthcare

Drug Development

Clinical Trials Clinical Research Regulatory Affairs FDA Approval Generic Drugs Cancer Treatment FDA Regulations Efficacy Studies Rare Diseases Psychedelic Drugs Antibiotic Discovery Eli Lilly Phase 2 Trials Market Competition Phase Studies Novo Nordisk Market Availability Alzheimer's Disease Experimental Treatments Jazz Pharmaceuticals Antibody-Drug Conjugates RNA-based Therapies Manufacturing Capacity Next-Generation Therapies B-cell Depletion Therapies Regulatory Approval Antiretroviral Drugs Pharmaceuticals Pharmaceutical Research Personalized Medicine Investigational Drugs

FDA Announces Phase-Out of Animal Testing for Antibody Therapies

New guidelines prioritize lab-grown human organoids, AI models, and organ-on-a-chip systems to modernize drug safety evaluations.

FDA Approves First New Oral Antibiotic for UTIs in Over 20 Years

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Sanofi and J&J Halt E. coli Vaccine Trial After Insufficient Efficacy

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal

Vertex Pain Drug Fails to Outperform Placebo in Key Study, Raising Concerns

Alberta Signs $162M Deal to Expand Access to Rare Disease Drugs

Cassava Sciences Halts Alzheimer’s Drug Trials Following Phase 3 Failure

FDA Approves Zanidatamab for Advanced HER2-Positive Biliary Tract Cancer

Eli Lilly's Oral Drug Shows Promise in Lowering Genetic Cholesterol

Novo Nordisk Expands Wegovy Supply Amid Compounding Drug Concerns

Ozempic and Wegovy Now Available After Prolonged Shortages

GSK Agrees to $2.2 Billion Settlement Over Zantac Cancer Claims

Breakthrough Alzheimer's Drug Targets Key Tau Protein Hotspots

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

Pioneers of Obesity Drugs Win Prestigious Lasker Award

Pfizer's New Drug Shows Promise in Combatting Cancer-Related Weight Loss

Weekly Insulin Shots Match Daily Injections in Diabetes Management

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study

New Migraine Drug Ubrogepant Shows Promise in Early Symptom Treatment

Scientists Discover New Antibiotics in Human Gut Microbiome

FDA Rejects MDMA-Assisted Therapy for PTSD, Citing Insufficient Evidence

UCLA Researchers Develop Molecule That Restores Memory in Alzheimer's Model Mice

FDA Approves Neffy: First Needle-Free Epinephrine Nasal Spray for Allergic Reactions

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety

FDA Approves Adaptimmune's Groundbreaking T-Cell Therapy for Rare Cancer

New Stem Cell Model Revolutionizes Parkinson’s Research

New HIV Prevention Shot Shows 100% Efficacy in Women

Congressional Hearing Intensifies Scrutiny on Pharmacy Benefit Managers